Temozolomide Capsules 100?mg × 5 – ChuanNuo (MySean) | Research Grade Glioblastoma Drug Subtotal: $1.00
Semaglutide Tablets 7?mg × 10 | Rybelsus® Oral GLP?1RA | Price comparison
$1.00
Rybelsus® oral semaglutide — 7?mg film-coated tablets, 10 per box, produced by Novo Nordisk A/S. The first FDA- and EMA-approved oral GLP?1 receptor agonist for type 2 diabetes. Ideal for metabolic, weight loss, and endocrinology research.
?? For laboratory research use only – Not for human consumption or therapeutic use.
描述
Semaglutide Tablets Description
Product name: Semaglutide tablets (Novo Nordisk/Rybelsus)
Packaging specifications: 7mg*10 tablets ? Product dosage form: tablets ? Packaging unit: box
Approval number: National Medicine Standard SJ20240005 ? Drug standard code: 86978997003475
Manufacturer: Novo Nordisk A/S, Denmark
Rybelsus® (semaglutide) 7?mg oral tablet is the world’s first approved GLP?1 receptor agonist in pill form, designed to improve glycemic control and support weight management in adults with type 2 diabetes. It mimics the incretin hormone GLP?1 to enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite?.
This innovative formulation uses an absorption enhancer (SNAC) to deliver semaglutide systemically — a breakthrough in peptide-based oral drug design.
Semaglutide Tablets Product Specifications
| Feature | Details |
|---|---|
| Product Name | Semaglutide Tablets (Rybelsus®) |
| Strength | 7?mg per film-coated tablet |
| Packaging | 10 tablets per box |
| Dosage Form | Oral tablet |
| Manufacturer | Novo Nordisk A/S |
| Approval Number | NMPA: SJ20240005 (China) |
| Product Code | 86978997003475 |
| Barcode | — |
| Origin | Denmark |
| Storage Conditions | Store ?30?°C, protect from moisture and light |
| Shelf Life | As labeled |
| Administration | Once daily on empty stomach with ?120?ml water; wait 30–60?min before food ? |
| Intended Use | For laboratory or analytical research only |
Semaglutide Tablets Mechanism & Clinical Highlights
-
GLP?1RA action: Boosts insulin, suppresses glucagon, delays gastric emptying, and reduces appetite?.
-
Approved dosing: 3?mg initial, titrating to 7?mg — with demonstrated HbA1c reductions of –1.0% (7?mg) and –1.3% (14?mg) compared to sitagliptin?.
-
Safety profile: Common side effects include nausea, diarrhea, and mild hypoglycemia (when used with other agents).
-
Pharmacokinetic note: Oral bioavailability is 0.4–1%, while injectable forms have ~89%, requiring oral dose adjustments.
? Why Choose Rybelsus® Semaglutide Tablets?
-
Global innovations: The first oral GLP?1RA with established clinical approval
-
Peptide delivery breakthrough: Oral SNAC-enhanced peptide absorption
-
Lab-ready film tablets: Precise dosage, stable, and easy to store
-
Supporting research: Excellent for appetite, weight, and metabolic studies
-
Semaglutide Injection (Ozempic® / Wegovy®)
-
Exenatide, Dulaglutide – GLP?1RA injectables
-
Metformin, Dapagliflozin – Oral antidiabetic agents
? Summary
Rybelsus® Semaglutide 7?mg tablets represent a pharmacological milestone — the first oral GLP?1 receptor agonist suitable for advanced metabolic, endocrinology, and appetite-control research. Produced by Novo Nordisk, with global regulatory backing and innovative peptide delivery, it’s perfect for labs exploring GLP?1PA mechanisms.
?? For laboratory research or analytical use only — not for human consumption or therapy.
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 26 × 25 × 26 厘米 |
Semaglutide Tablets 7?mg × 10 | Rybelsus® Oral GLP?1RA | Price comparison 有 2 个评价
相关产品
-
Mixed Protamine Human Insulin 30R Injection Pen Refill – Yibolin 300?IU (3?ml)
Mixed Protamine Human Insulin (30R) – 300 IU in a 3?ml pen refill cartridge, combining 30?% regular and 70?% NPH insulin. Produced by Yichang Dongyangguang, ideal for research into glucose regulation, insulin pharmacokinetics, and diabetes models.
?? For laboratory research use only – not for human consumption or therapeutic use. $1.00 -
Liraglutide Injection 18?mg/3?ml Prefilled Pen | Tonboli by Tonghua Dongbao |
Liraglutide 18?mg in a 3?ml prefilled pen, branded Tonboli, produced by Tonghua Dongbao Pharmaceutical Co., Ltd. Approved under NMPA S20230066, ideal for GLP?1 receptor agonist research, metabolic studies, and diabetes modelling.
?? For laboratory research use only – Not for human consumption or therapeutic use. $2.00 -
Proline?+?Dapagliflozin Tablets 50mg:5mg Price comparison
Huiyoujing – Proline + Dapagliflozin Tablets 50mg/5mg, 14 tablets/box. Innovative dual SGLT-2 class?1 drug, ?? Reminder: strictly for laboratory research use only. $2.00 -
Sitagliptin and Metformin Hydrochloride Extended-Release Tablets – For Laboratory Use Only
Formulated for laboratory research use, Sitagliptin and Metformin Hydrochloride Extended-Release Tablets combine a DPP-4 inhibitor and biguanide. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd., approved under H20253718.?For wholesale prices, other specifications and uses, please consult our staff?
$1.00
mnsdz –
Received it, but the logistics took too long, I waited for 12 days
djinie –
Awesome, my brother